Tweedy Browne Funds 3Q15 ” we welcomed the market turbulence”

Tweedy Browne Funds 3Q15 ” we welcomed the market turbulence”

Tweedy Browne commentary for the third quarter ended September 30, 2015.

H/T Dataroma

The third quarter in global equity markets was characterized by a dramatic increase in equity market volatility, seemingly driven in large part by concerns about slowing growth in China, the devaluation of the yuan, volatile oil prices, and the prospect for an increase in U.S. interest rates. While the Tweedy Browne Funds finished the quarter in the red, all, with the exception of the Worldwide High Dividend Yield Value Fund, bested their respective benchmark indices, with our two international Funds, Global Value and Global Value II, doing so by a considerable margin. Near quarter-end, equity markets began to rebound, and as we write, they have regained much of the ground that was lost in August and early September, and the same holds true for the Tweedy Browne Funds.

David Einhorn At The 2021 Sohn Investment Conference: Buy These Copper Plays

david einhorn, reading, valuewalk, internet, investment research, Greenlight Capital, hedge funds, Greenlight Masters, famous hedge fund owners, big value investors, websites, books, reading financials, investment analysis, shortselling, investment conferences, shorting, short biasThere's a gold rush coming as electric vehicle manufacturers fight for market share, proclaimed David Einhorn at this year's 2021 Sohn Investment Conference. Check out our coverage of the 2021 Sohn Investment Conference here. Q1 2021 hedge fund letters, conferences and more SORRY! This content is exclusively for paying members. SIGN UP HERE If you Read More

While we welcomed the market turbulence during the quarter for the opportunities such events often present to price sensitive investors such as ourselves, our Fund portfolios temporarily lost some ground on an absolute basis. Solid returns in several of the Funds’ food, beverage and tobacco holdings, including Nestlé, Heineken, Embotelladora Andina, and Imperial Tobacco; a nice bounce in our Korean auto companies, Hyundai Motor and Kia; solid results in aerospace holding Safran; and a strong return in Google were simply not enough to offset declines in the Funds’ financial, energy, pharmaceutical, and industrial holdings, i.e. banks and insurance companies such as Standard Chartered, DBS Group, CNP, and Zurich Insurance; energy companies such as Devon Energy, Royal Dutch, Total, and Halliburton; pharmaceutical holdings including GlaxoSmithKline, Novartis, and Johnson & Johnson; and industrials such as Emerson Electric, Vallourec, and G4S, among others. We also faced a decline in our lone mining holding, Antofagasta, the financially strong Chilean copper mining company. As we write, all of these stocks, with the exception of Novartis, have rallied back, well above their quarter-end prices.

The volatility during the quarter led to a considerable pick-up in portfolio activity in our Funds as we were able to take advantage of pricing opportunities to establish a new position in MRC Global, a U.S. based distributor of pipes, valves and fittings, largely to the oil and gas industry; Ebara, a Japanese manufacturer of pumps, compressors, and incinerators; and IBM, the global information technology company. All three of these companies at purchase were trading at significant discounts from our conservative estimates of their respective intrinsic values, and we believe they are financially strong and have attractive prospects for future growth in intrinsic value. In addition to the establishment of these new positions, we also added to our preexisting positions in Antofagasta, Hyundai Motor, Kia, Diageo, Standard Chartered, United Overseas Bank, and Royal Dutch.

On the sell side of our Fund portfolios, we sold our positions in Eni and National Oilwell Varco, which we concluded would have a difficult time making financial progress if oil prices stay low for longer than expected. We also sold our positions in Leucadia and Schindler, which had reached our estimate of intrinsic value, and trimmed our positions in Headlam, Novartis, and Roche.

With the return of volatility and a healthy dose of skepticism in markets during the quarter, we began to see valuations come back into what we believe to be a more reasonable relationship with our view of underlying business values and their future prospects. If this continues, as we suspect it will, despite the rebound over the last several weeks, we feel we are well positioned to take meaningful advantage.

Thank you for investing with us and for your continued confidence.

Tweedy Browne Company LLC

William H. Browne
Thomas H. Shrager
John D. Spears
Robert Q. Wyckoff, Jr.

Managing Directors

No posts to display